Clinical Trials Directory

Trials / Completed

CompletedNCT04111146

Effect of 25-OH-vitamin D3 on the Liver Transplant Recipients

The Clinical Effect of Preoperative Level of 25-OH-vitamin D3 on the Liver Transplant Recipients

Status
Completed
Phase
Study type
Observational
Enrollment
219 (actual)
Sponsor
Asan Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The low vitamin D3 levels and malnutrition before liver transplantation showed an increase in the length of stay in ICU and hospital. Although several factors may influence the clinical outcomes of patients with liver transplantation, low vitamin D3 levels showed an independent risk factor. It is necessary to prospectively analyze the effect of vitamin D supplements on clinical outcomes in liver transplant recipients.

Detailed description

Purpose: Vitamin D deficiency is common in patients of chronic liver disease and has been associated with infection and mortality. The aim of this study is to determine whether preoperative vitamin D levels affect clinical outcomes after liver transplantation. Methods : This was a single-center retrospective study. Between June and November 2017, a total of 219 patients underwent liver transplantation. The primary outcome was the relationship between serum 25-OH-vitamin D3 level before liver transplantation and length of stay in the intensive care unit (ICU). Secondary outcomes included the duration of normalization of inflammatory marker, such as white blood cell count (WBC) \& C-reactive protein (CRP) after liver transplantation, new infection rates, rejection rates, the length of hospital stay and mortality among vitamin D level.

Conditions

Timeline

Start date
2017-06-01
Primary completion
2017-11-30
Completion
2019-06-30
First posted
2019-10-01
Last updated
2019-10-01

Locations

1 site across 1 country: South Korea

Source: ClinicalTrials.gov record NCT04111146. Inclusion in this directory is not an endorsement.